RPS6KA3 and mantle cell lymphoma: These suggest that normal lymphocytes are less addicted to RSK2 activity compared with MCL cells, and we expect that the difference in the dependency to RSKSer227 between MCL and normal lymphocyte may produce the chance for targeted treatment against RSK2Ser227.